These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6833271)

  • 1. Direct and reversible inhibition of estradiol-stimulated prolactin synthesis by antiestrogens in vitro.
    Lieberman ME; Jordan VC; Fritsch M; Santos MA; Gorski J
    J Biol Chem; 1983 Apr; 258(8):4734-40. PubMed ID: 6833271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018.
    Jordan VC; Gosden B
    Endocrinology; 1983 Aug; 113(2):463-8. PubMed ID: 6872937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by tamoxifen of estrogen-stimulated accumulation of preprolactin messenger ribonucleic acid.
    Spona J; Leibl H
    Biochim Biophys Acta; 1981 Nov; 656(1):45-54. PubMed ID: 7306549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An estrogen receptor model to describe the regulation of prolactin synthesis by antiestrogens in vitro.
    Lieberman ME; Gorski J; Jordan VC
    J Biol Chem; 1983 Apr; 258(8):4741-5. PubMed ID: 6833272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential antiestrogen action in the immature rat uterus: a comparison of hydroxylated antiestrogens with high affinity for the estrogen receptor.
    Jordan VC; Gosden B
    J Steroid Biochem; 1983 Sep; 19(3):1249-58. PubMed ID: 6684713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogens are partial estrogen agonists for prolactin production in primary pituitary cultures.
    Martinez-Campos A; Amara JF; Dannies PS
    Mol Cell Endocrinol; 1986 Dec; 48(2-3):127-33. PubMed ID: 3803705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements for the pharmacological activity of nonsteroidal antiestrogens in vitro.
    Jordan VC; Lieberman ME; Cormier E; Koch R; Bagley JR; Ruenitz PC
    Mol Pharmacol; 1984 Sep; 26(2):272-8. PubMed ID: 6482874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of antiestrogen stimulation of cell number and prolactin production.
    Amara JF; Dannies PS
    Mol Cell Endocrinol; 1986 Oct; 47(3):183-9. PubMed ID: 3758472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of prolactin synthesis in vitro by estrogenic and antiestrogenic derivatives of estradiol and estrone.
    Jordan VC; Koch R
    Endocrinology; 1989 Apr; 124(4):1717-26. PubMed ID: 2924721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiestrogen action in the medial basal hypothalamus and pituitary of immature female rats: insights concerning relationships among estrogen, dopamine, and prolactin.
    Toney TW; Katzenellenbogen BS
    Endocrinology; 1986 Dec; 119(6):2661-9. PubMed ID: 3780547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tamoxifen on serum prolactin levels, pituitary immunoreactive prolactin cells and uterine growth in estradiol-treated ovariectomized rats.
    Spritzer PM; Ribeiro MF; Oliveira MC; Barbosa-Coutinho LM; Silva IS; Dahlem N; Cericatto R; Pavanato MA
    Horm Metab Res; 1996 Apr; 28(4):171-6. PubMed ID: 8740191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
    Dix CJ; Jordan VC
    Endocrinology; 1980 Dec; 107(6):2011-20. PubMed ID: 7191796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the mechanism of the inhibitory actions of catecholestrogens, tamoxifen and high concentrations of estrogens on prolactin release by cultured rat pituitary tumor cells.
    Lamberts SW; Verleun T
    Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1117-23. PubMed ID: 2820746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the metabolic activation of non-steroidal antioestrogens: a study of structure-activity relationships.
    Allen KE; Clark ER; Jordan VC
    Br J Pharmacol; 1980; 71(1):83-91. PubMed ID: 7470748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antiestrogens on pituitary prolactin production in normal and pituitary tumor-bearing rats.
    Nagy I; Valdenegro CA; MacLeod RM
    Neuroendocrinology; 1980 Jun; 30(6):389-95. PubMed ID: 7383277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 17 beta-estradiol, synthetic estrogens, and antiestrogens on prolactin secretion, nuclear translocation of pituitary estrogen receptor and on progesterone receptor levels in rat pituitary, hypothalamus and uterus.
    Leibl H; Bieglmayer C; Spona J
    Endocrinol Exp; 1981; 15(1):35-44. PubMed ID: 6971219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen interaction with the anterior pituitary of female rats: Differential cytosol binding, nuclear translocation and stimulation of RNA synthesis by 17 beta-estradiol and tamoxifen.
    Spona J; Bieglmayer C; Leibl H
    Biochim Biophys Acta; 1980 Dec; 633(3):361-75. PubMed ID: 6163453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-stimulated prolactin synthesis in vitro. Classification of agonist, partial agonist, and antagonist actions based on structure.
    Jordan VC; Lieberman ME
    Mol Pharmacol; 1984 Sep; 26(2):279-85. PubMed ID: 6541293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen- and antiestrogen-induced ornithine decarboxylase activity and uterine growth in the rat.
    Branham WS; Leamons ML; Sheehan DM
    J Steroid Biochem; 1988 Feb; 29(2):153-9. PubMed ID: 3347055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.